Patient friendly, Personalized care and Preventing disease
View our productAdvanced Glycation Endproducts play a key role in the development of chronic age-related diseases such as diabetes, renal failure and cardiovascular disease.
Read moreAdvanced Glycation Endproducts play a key role in the development of chronic age-related diseases such as diabetes, renal failure and cardiovascular disease.
Read moreWould you like to learn more about our products? Request any information you wish to receive here.
We're thrilled to announce a significant leadership change at Diagnoptics as John Mulder becomes our new CEO per 21 august 2023. Bringing extensive marketing and management...
» Read moreThe AGE Reader and Diab-spot have received approval in a number of countries. Please check with the distributor in your country or Diagnoptics what the regulatory approval status is in your country. US Caution: Federal law restricts the AGE Reader and Diab-spot system to investigational use only. Commercial distribution has not been granted by the US FDA. Please see the AGE Reader and Diab-spot user manuals for descriptions of all relevant warnings, cautions, contraindications and safety information.
More information about Diagnoptics.
Information on Diagnoptics' products and Advanced Glycation Endproducts.
Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.